TABLE 1.
Dog | Cat | ||||
---|---|---|---|---|---|
Month‐Year | Sample | ELISAa positive [suspected]/test (% positive) | sVNTb positive/test (% positive) | ELISAa positive [suspected]/test (% positive) | sVNTb positive/test (% positive) |
Apr‐20 | 504 | 4[3]/311 (1.29%) | 0/7 | 1[1]/193 (0.52%) | 0/2 |
May‐20 | 412 | 3[1]/213 (1.41%) | 0/4 | 3[0]/199 (1.51%) | 0/3 |
Jun‐20 | NA | NA | NA | NA | NA |
Jul‐20 | 459 | 6[2]/278 (2.16%) | 0/8 | 0/181 | 0 |
Aug‐20 | 523 | 12[2]/374 (3.21%) | 0/14 | 0/149 | 0 |
Sep‐20 | 581 | 5[0]/401 (1.25%) | 0/5 | 0/180 | 0 |
Oct‐20 | 175 | 0/115 | 0 | 0/60 | 0 |
Nov‐20 | 175 | 2[1]/120 (1.67%) | 0/3 | 0/55 | 0 |
Dec‐20 | 386 | 3[0]/291 (1.03%) | 0/3 | 0[1]/95 | 0/1 |
3215 | 35[9]/2103 (1.66%) | 0/44 | 4[2]/1112 (0.36%) | 0/6 |
aIndirect ELISA: ID Screen® SARS‐CoV‐2 Double Antigen Multi‐species ELISA kit (ID VET, Montpellier, France). For the cut‐off values, S/P% > 60% is positive, S/P% 50−60% is suspect and < 50% is negative.
bsVNT: cPass™ SARS‐CoV‐2 Neutralization Antibody Detection Kit (GenScript Biotech, Jiangsu, China). The cut‐off values were defined as follows: positive of % inhibition > 20% and negative otherwise.